Nestle Healthcare Nutrition, Inc. (Nestle) is facing a class-action lawsuit over claims that its Boost Glucose Control drinks help diabetic consumers manage their blood sugar levels. The case, Owen v. Nestle Healthcare Nutrition, Inc., was filed in New Jersey District Court. The suit alleges that Nestle makes druglike claims about the drinks, which have not been tested or approved by the Food and Drug Administration (FDA), and that the products mislead consumers into believing that the drinks help control blood glucose levels when in fact Nestle's own study revealed they do not.
Plaintiff Steven Owen's lawsuit involves Nestle's BOOST-brand Glucose Control over-the-counter drinks with the name "Glucose Control." As described in his complaint, the products are labeled "Glucose Control" and prominently state in bold, capitalized font that they "HELP MANAGE BLOOD SUGAR" and/or that they are "DESIGNED FOR PEOPLE WITH DIABETES."
Plaintiff, a diagnosed diabetic, purchased a 24-pack of BOOST Glucose Control in or around April 2022 from Amazon for $38.99. He claims that the products did not "control" his Glucose or "manage his blood sugar" as he expected it would in light of the product's labeling. "Defendant's prominent and systematic mislabeling of the Products and its false and deceptive advertising form a pattern of unlawful and unfair business practices that harms the public and, if unstopped, could continue to lead to substantial...
Bhubaneswar: Family members and villagers of lynch victim Soumya Ranjan Swain on Saturday demanded a polygraph test on the woman who accused him of attempting rape on a busy road in Balianta area ...